-
公开(公告)号:US20240108607A1
公开(公告)日:2024-04-04
申请号:US18112423
申请日:2023-02-21
Applicant: FUJIFILM Corporation
Inventor: Hirofumi FUKUNAGA , Sachiko SHINJO , Daisuke NAKAGAWA , Shinichiro SEKINE , Takayuki YAMAKAWA
IPC: A61K31/4375 , A61K31/145 , A61K31/223 , A61K31/27 , A61K31/395 , A61K31/555 , A61K31/785 , A61K51/00 , C07B59/00 , C07D255/02 , C07D257/02 , C07D471/04 , C07D487/00 , C07F1/08 , C07F5/00
CPC classification number: A61K31/4375 , A61K31/145 , A61K31/223 , A61K31/27 , A61K31/395 , A61K31/555 , A61K31/785 , A61K51/00 , C07B59/00 , C07D255/02 , C07D257/02 , C07D471/04 , C07D487/00 , C07F1/08 , C07F5/00
Abstract: A compound represented by Formula [3] or a salt thereof and a method of making the
in the formula, L3 represents a group represented by Formula [2c]
wherein R3c, R4c, R5c and R6c are the same as or different from each other and represent a hydrogen atom or a C1-6 alkyl group; p3 represents an integer of 1 to 3; q3 represents an integer of 0 to 3; and r3 represents an integer of 1 to 6; A1 represents any one of the groups represented by Formulae [4] to [9],
wherein * represents a binding position; and R7 represents a carboxyl-protecting group; and m represents an integer of 1 to 3.-
2.
公开(公告)号:US20230167074A1
公开(公告)日:2023-06-01
申请号:US18160690
申请日:2023-01-27
Applicant: FUJIFILM Corporation
Inventor: Takayuki YAMAKAWA , Yasuhiro TSUTSUI
IPC: C07D241/28 , A61P35/02 , C07D405/12 , C07D401/12 , C07D405/14 , C07D413/14 , C07D405/04
CPC classification number: C07D241/28 , A61P35/02 , C07D405/12 , C07D401/12 , C07D405/14 , C07D413/14 , C07D405/04
Abstract: An object of the present invention is to provide a compound useful as an anti-tumor agent or the like; an intermediate thereof; and a pharmaceutical composition, an anti-tumor agent, and a dihydroorotate dehydrogenase inhibitor, each of which contains the compound. According to the present invention, there is provided a compound represented by General Formula (1) or a salt thereof:
in the formula, Z1, Z2, and Z3 are the same as or different from each other and represent a nitrogen atom or CH; Z4 represents a nitrogen atom or a general formula of CR6; Z5 represents a nitrogen atom or a general formula of CR7 provided that at least one of Z1, Z2, Z3, Z4, or Z5 represents a nitrogen atom; R1 represents a general formula of CONHR8 or the like; R2 represents a C3-8 cycloalkyl group which may be substituted or the like; R3, R5, R6, and R7 are the same as or different from each other and represent a hydrogen atom, a halogen atom, or the like; R4 represents an aryl group which may be substituted or a heterocyclic group which may be substituted; R8 represents a general formula of SO2R9 or the like; and R9 represents an amino group which may be protected or the like.-
公开(公告)号:US20220259185A1
公开(公告)日:2022-08-18
申请号:US17732717
申请日:2022-04-29
Applicant: FUJIFILM Corporation
Inventor: Takayuki YAMAKAWA , Yasuhiro Tsutsui
IPC: C07D405/12
Abstract: An object of the present invention is to provide a compound useful as an anti-tumor agent or the like, as well as a pharmaceutical composition, an anti-tumor agent, and a dihydroorotate dehydrogenase inhibitor, each of which contains the compound. According to the present invention, a compound represented by General Formula (1) or a salt thereof is provided. In the formula, R1 represents a hydrogen atom or a C1-6 alkyl group; R2, R3, R4, and R5 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, a C1-6 alkyl group which may be substituted, a C1-6 alkoxy group which may be substituted, or the like; R6's are the same as or different from each other and each represent a halogen atom, a C1-6 alkyl group which may be substituted, or a C1-6 alkoxy group which may be substituted; R7 represents a C3-8 cycloalkyl group which may be substituted, or the like; m represents an integer of 0 to 6; and a broken line represents a single bond or a double bond.
-
公开(公告)号:US20210015802A1
公开(公告)日:2021-01-21
申请号:US17037103
申请日:2020-09-29
Applicant: FUJIFILM Corporation
Inventor: Hirofumi FUKUNAGA , Sachiko SHINJO , Daisuke NAKAGAWA , Shinichiro SEKINE , Takayuki YAMAKAWA
IPC: A61K31/4375 , A61K31/395 , A61K31/555 , C07F5/00 , C07D257/02 , C07D255/02 , C07F1/08 , C07D471/04 , A61K51/00 , C07B59/00 , A61K31/145 , A61K31/223 , A61K31/27 , A61K31/785 , C07D487/00
Abstract: A compound represented by Formula [3] or a salt thereof and a method of making the same, in the formula, L3 represents a group represented by Formula [2c] wherein R3c, R4c, R5c, and R6c are the same as or different from each other and represent a hydrogen atom or a C1-6 alkyl group; p3 represents an integer of 1 to 3; q3 represents an integer of 0 to 3; and r3 represents an integer of 1 to 6; A1 represents any one of the groups represented by Formulae [4] to [9], wherein * represents a binding position; and R7 represents a carboxyl-protecting group; and m represents an integer of 1 to 3.
-
公开(公告)号:US20180008583A1
公开(公告)日:2018-01-11
申请号:US15712815
申请日:2017-09-22
Applicant: FUJIFILM Corporation
Inventor: Hirofumi FUKUNAGA , Sachiko SHINJO , Daisuke NAKAGAWA , Shinichiro SEKINE , Takayuki YAMAKAWA
IPC: A61K31/4375 , A61K31/27 , A61K31/145 , A61K31/223 , C07D487/00 , A61K31/785
Abstract: Provided are a method for efficiently manufacturing a nitrogen-containing compound, which is used for manufacturing a treatment agent for integrin-related diseases, or a salt thereof and a manufacturing intermediate of the compound or a salt thereof.A method for manufacturing a novel nitrogen-containing compound or a salt thereof includes (1) a step of obtaining a compound represented by Formula [10] or a salt thereof through an amidation reaction; and (2) a step of deprotecting the compound represented by Formula [10] or a salt thereof.
-
-
-
-